Meridian Bioscience Inc.

NASDAQ:VIVO   3:59:51 PM EDT
20.17
+0.52 (+2.65%)
Products

Meridian Resubmits Application To FDA For Emergency Use Authorization For Revogene Sars-Cov-2 Molecular Assay

Published: 06/28/2021 13:50 GMT
Meridian Bioscience Inc. (VIVO) - Meridian Resubmits Application to FDA for Emergency Use Authorization for Revogene Sars-cov-2 Molecular Assay.